Casari G, Romaldi B, Scire A, Minnelli C, Marzioni D, Ferretti G
Biomolecules. 2025; 15(1).
PMID: 39858410
PMC: 11762081.
DOI: 10.3390/biom15010015.
Fukumoto W, Okamura S, Tamai M, Arima J, Kawahara I, Fukuda I
BMC Cancer. 2024; 24(1):1333.
PMID: 39472827
PMC: 11523841.
DOI: 10.1186/s12885-024-13109-5.
Huang P, Zhao H, Sun R, Liu C, Wu L, Wang Y
Sci Rep. 2024; 14(1):11211.
PMID: 38755247
PMC: 11099075.
DOI: 10.1038/s41598-024-61261-6.
Kazemi Shariat Panahi H, Dehhaghi M, Guillemin G, Peng W, Aghbashlo M, Tabatabaei M
Cancer Metastasis Rev. 2023; 43(2):657-672.
PMID: 37910296
DOI: 10.1007/s10555-023-10142-x.
Wang L, Zhang K, Feng J, Wang D, Liu J
Cancer Manag Res. 2023; 15:811-821.
PMID: 37589033
PMC: 10426457.
DOI: 10.2147/CMAR.S418574.
MiR-218-5p/EGFR Signaling in Arsenic-Induced Carcinogenesis.
Islam R, Zhao L, Zhang X, Liu L
Cancers (Basel). 2023; 15(4).
PMID: 36831545
PMC: 9954652.
DOI: 10.3390/cancers15041204.
MicroRNA signature of small-cell lung cancer after treatment failure: impact on oncogenic targets by miR-30a-3p control.
Tanigawa K, Misono S, Mizuno K, Asai S, Suetsugu T, Uchida A
Mol Oncol. 2022; 17(2):328-343.
PMID: 36345848
PMC: 9892828.
DOI: 10.1002/1878-0261.13339.
Molecular Aberrations in Periampullary Carcinoma.
Tewari M, Swain J, Dixit V, Shukla H
Indian J Surg Oncol. 2022; 8(3):348-356.
PMID: 36118392
PMC: 9478047.
DOI: 10.1007/s13193-017-0645-2.
CircCEMIP promotes anoikis-resistance by enhancing protective autophagy in prostate cancer cells.
Yu Y, Song Y, Cheng L, Chen L, Liu B, Lu D
J Exp Clin Cancer Res. 2022; 41(1):188.
PMID: 35655258
PMC: 9161511.
DOI: 10.1186/s13046-022-02381-7.
MicroRNA-218-5p affects lung adenocarcinoma progression through targeting endoplasmic reticulum oxidoreductase 1 alpha.
Chen G, Wang Q, Wang K
Bioengineered. 2022; 13(4):10061-10070.
PMID: 35441565
PMC: 9161986.
DOI: 10.1080/21655979.2022.2063537.
microRNA-99a-5p induces cellular senescence in gemcitabine-resistant bladder cancer by targeting SMARCD1.
Tamai M, Tatarano S, Okamura S, Fukumoto W, Kawakami I, Osako Y
Mol Oncol. 2022; 16(6):1329-1346.
PMID: 35148461
PMC: 8936529.
DOI: 10.1002/1878-0261.13192.
Elevated Expression of JMJD5 Protein Due to Decreased miR-3656 Levels Contributes to Cancer Stem Cell-Like Phenotypes under Overexpression of Cancer Upregulated Gene 2.
Yawut N, Cho I, Budluang P, Kaowinn S, Kaewpiboon C, Jeon B
Biomolecules. 2022; 12(1).
PMID: 35053270
PMC: 8774111.
DOI: 10.3390/biom12010122.
Identification of and Target Genes: Paxillin Facilities Cancer Cell Aggressiveness in Head and Neck Squamous Cell Carcinoma.
Tanaka N, Minemura C, Asai S, Kikkawa N, Kinoshita T, Oshima S
Genes (Basel). 2021; 12(12).
PMID: 34946859
PMC: 8701835.
DOI: 10.3390/genes12121910.
Circulating microRNAs and Molecular Oxidative Stress in Older Adults with Neuroprogression Disorders.
Al-Rawaf H, Alghadir A, Gabr S
Dis Markers. 2021; 2021:4409212.
PMID: 34721735
PMC: 8556086.
DOI: 10.1155/2021/4409212.
Circular RNA TAF4B Promotes Bladder Cancer Progression by Sponging miR-1298-5p and Regulating TGFA Expression.
Zhang X, Li X, Fu X, Yu M, Qin G, Chen G
Front Oncol. 2021; 11:643362.
PMID: 34322376
PMC: 8312550.
DOI: 10.3389/fonc.2021.643362.
Angiogenesis-related non-coding RNAs and gastrointestinal cancer.
Razavi Z, Asgarpour K, Mahjoubin-Tehran M, Rasouli S, Khan H, Shahrzad M
Mol Ther Oncolytics. 2021; 21:220-241.
PMID: 34095461
PMC: 8141508.
DOI: 10.1016/j.omto.2021.04.002.
NCAPG upregulation mediated by four microRNAs combined with activation of the p53 signaling pathway is a predictor of poor prognosis in patients with breast cancer.
Dong M, Xu T, Cui X, Li H, Li X, Xia W
Oncol Lett. 2021; 21(4):323.
PMID: 33692855
PMC: 7933778.
DOI: 10.3892/ol.2021.12585.
EHHADH contributes to cisplatin resistance through regulation by tumor-suppressive microRNAs in bladder cancer.
Okamura S, Yoshino H, Kuroshima K, Tsuruda M, Osako Y, Sakaguchi T
BMC Cancer. 2021; 21(1):48.
PMID: 33430801
PMC: 7798329.
DOI: 10.1186/s12885-020-07717-0.
ERα increases endometrial cancer cell resistance to cisplatin via upregulation of BAG3.
Abe S, Iwasaki M, Habata S, Mariya T, Tamate M, Matsuura M
Oncol Lett. 2020; 21(1):20.
PMID: 33240426
PMC: 7681203.
DOI: 10.3892/ol.2020.12281.
Immune-related miRNA signature identifies prognosis and immune landscape in head and neck squamous cell carcinomas.
Ma B, Li H, Qiao J, Meng T, Yu R
Biosci Rep. 2020; 40(11).
PMID: 33111959
PMC: 7670576.
DOI: 10.1042/BSR20201820.